Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats

American Journal of Physiology

Volumn 273, Issue 2 PART 2, 1997, Pages

  Gao, Hubin ^a   Welch, William J ^a   DiBona, Gerald F ^b   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030769143     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 2 and renovascular hypertension in rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1190-R1197, 1994.
2. Byrne, J. G., R. F. Appleyard, S.-C. Sun, G. S. Couper, J. A. Sloane, R. G. Laurence, and L. H. Cohn. Cardiac-derived thromboxane A2: an initiating mediator of reperfusion injury? J. Thorac. Cardiovasc. Surg. 105: 689-693, 1993.
3. Folger, W. H., D. Lawson, C. S. Wilcox, and J. L. Mehta. Response of rat thoracic aortic rings to thromboxane mimetic U-46619: roles of endothelium-derived relaxing factor and thromboxane A2 release. J. Phartnacol. Exp. Ther. 258: 669-675, 1991.
4. Gao, H., B. Peng, W. J. Welch, and C. S. Wilcox. Thromboxane receptors in the rat brain: mRNA expression and function in blood pressure regulation (Abstract). FASEB J. 10: A334, 1996.
5. Geoffroy, J., D. Benzoni, M. Vincent, and J. Sassard. Thromboxane A2 and development of genetic hypertension in the Lyon rat strain. Hypertension 16: 665-671, 1990.
6. Himmelstein, S. I., and P. E. Klotman. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F190-F196, 1989.
7. Lee, S.-L., S. Levitsky, and H. Feinberg. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction. J. Pharmacol. Exp. Ther. 258: 292-298, 1991.
8. 2-mediated mechanism of vascular contraction in hypertensive rats: relation to lipoxygenase and prostacyclin synthase activities. Circ. Res. 74: 197-205, 1994.
9. Liu, K. L., A. Hadj Aissa, M. C. Lareal, D. Benzoni, M. Vincent, and J. Sassard. Adrenergic stimulation of renal prostanoids in the Lyon hypertensive rat. Hypertension 17: 296-302, 1991.
10. Luft, F. C., C. S. Wilcox, T. Unger, R. Kuhn, G. Demmert, P. Rohmeiss, D. Ganten, and R. B. Sterzel. Angiotensin-induced hypertension in the rat: sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
11. 2 for their receptor are similar in washed human platelets. Kochern. Biophys. Res. Commun. 157: 733-739, 1988.
12. Mistry, M., and A. Nasjletti. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. J. Pharmacol. Exp. Ther. 253: 90-94, 1990.
13. Morrow, J. D., and L. J. Roberts II. The isoprostanes. Biochem. Pharmacol. 51: 1-9, 1996.
14. 2/ prostaglandin endoperoxide receptor antagonist. J. Pharmacol. Exp. Ther. 264: 570-578, 1993.
15. Purkerson, M. L., K. J. Martin, J. Yates, J. M. Kissane, and S. Klahr. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats. Hypertension 8: 1113-1120, 1986.
16. 2 receptor in the vasoconstrictor response of rat aorta to endothelin. J. Pharmacol. Exp. Ther. 252: 915-921, 1990.
17. Robinette, J. B., and J. D. Conger. Angiotensin and thromboxane in the enhanced renal adrenergic nerve sensitivity of acute renal failure. J. Clin. Invest. 86: 1532-1539, 1990.
18. Sakuma, I., S. S. Gross, and R. Levi. Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover. Can. J. Physiol. Pharmacol. 67: 943949, 1989.
19. Stein, E. A., and G. J. Trachte. Thromboxane mimetics enhance adrenergic neurotransmission in the rabbit-isolated portal vein. J. Cardiouasc. Pharmacol. 14: 469-474, 1989.
20. Trachte, G. J., and E. A. Stein. Thromboxane receptor antagonists enhance adrenergic neurotransmission in rabbit isolated mesenteric arteries. J. Pharmacol. Exp. Ther. 249: 216-220, 1989.
21. 2 in Dahl genetical strain susceptible to salt-induced hypertension. Prostaglandins 33: 727-738, 1987.
22. Welch, W. J., N. G. Ahlstrom, and C. S. Wilcox. Mechanism of hypertension during prolonged infusion of thromboxane mimetic. Ear. J. Int. Med. 2: 277-280, 1992.
23. Welch, W. J., X. Deng, H. Snellen, and C. S. Wilcox. Valida tion of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F175-F178, 1995.
24. Welch, W. J., B. Peng, and C. S. Wilcox. Salt intake determines renal thromboxane receptor mRNA expression and function in tubuloglomerular feedback (Abstract). FASEB J. 10: A546, 1996.
25. Welch, W. J., and C. S. Wilcox. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J. Clin. Invest. 89: 1857-1865, 1992.
26. 2 receptors maintain hypertension throughout 2K, 1C Goldblatt hypertension in the rat. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R891-R896, 1996.
27. Wilcox, C. S., W. H. Folger, and W. J. Welch. Renal vasoconstriction with U-46619: role of arachidonate metabolites. J. Am. Soc. Nephrol. 5: 1120-1124, 1994.
28. Wilcox, C. S., W. J. Welch, and H. Snellen. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int. 40: 1090-1097, 1991.
29. 2 receptors. J. Pharmacol. Exp. Ther. 263: 905-909, 1992.